Actively Recruiting
Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional Symptoms
Led by Mónica Larrosa Signorelli · Updated on 2026-04-01
48
Participants Needed
1
Research Sites
36 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates the efficacy of a group-based Acceptance and Commitment Therapy (ACT) protocol compared to a non-directive group therapy used as an active control condition in university students presenting moderate to moderate/high levels of emotional symptomatology. Emotional difficulties such as depressive and anxiety symptoms are highly prevalent among university students and may negatively affect academic performance, well-being, and long-term functioning. Acceptance and Commitment Therapy (ACT) is an evidence-based psychological intervention that aims to improve mental health by increasing psychological flexibility, the ability to act in accordance with personal values while remaining open to difficult internal experiences. Participants will be randomly assigned to either (1) a structured ACT group intervention or (2) a non-directive supportive group intervention that controls for therapeutic attention and group support factors. The primary hypothesis is that participants receiving ACT will show greater reductions in emotional symptoms and greater improvements in psychological flexibility compared to the active control group. Outcomes will include depressive and anxiety symptoms, psychological flexibility, repetitive negative thinking, and meaning in life. The study uses a multimethod assessment strategy combining traditional self-report questionnaires administered at baseline, post-intervention, and follow-up; Ecological Momentary Assessment (EMA) with daily and weekly measures during the intervention period; and qualitative interviews to explore participants' experiences.
CONDITIONS
Official Title
Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- University students aged 18 to 28 years.
- Score 6 on the PHQ-9.
- Score 6 on the GAD-7.
- Willingness to participate in a longitudinal study including pre-, post-, and follow-up assessments.
- Willingness to complete daily and weekly ecological momentary assessments (EMA).
- Provision of written informed consent.
You will not qualify if you...
- Suicide risk based on clinical indicators derived from PHQ-9 assessment.
- Self-reported history of psychotic disorders.
- Self-reported problematic substance use.
- Failure to provide informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universidad de Montevideo
Montevideo, Montevideo Department, Uruguay, 11600
Actively Recruiting
Research Team
M
Mónica Larrosa Signorelli, Lic. Psic., Mgtr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here